Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'

Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023.

“Wall Street likes profitable companies with consistent results, nice dividends and reasonably valued stocks,” Cramer said according to a CNBC report.“The biggest [health care] winners were boring, consistent operators with cheap stocks,” he added.

Also Read: Gold IRA Kit

The year saw financial markets across asset classes witness a significant rout following the war in Ukraine, rising inflation and co-ordinated efforts by central banks around the world to rein-in price rises. Cramer pointed out that healthcare shares have stayed relatively stable this year as they are recession-proof stocks. Following are the five scrips that he presented:

-- Danaher Corporation DHR: Cramer has projected that the company will have a banner year in 2023 while terming it as “one of the best-run companies in any industry.” Danaher shares have lost over 14% since the beginning of this year.

-- Pfizer Limited PFE: The market expert believes Pfizer stock is a steal as he praised the company’s acquisition of Arena Pharmaceuticals, Biohaven Ltd BHVN and Global Blood Therapeutics. Shares of Pfizer have lost over 5% this year.

-- UnitedHealth Group Inc UNH: Cramer stated he likes the “best-of-breed” managed health care stock. The stock has gained over 5% this year.

-- Humana Inc HUM: The expert believes this stock is a great turnaround story. In a year where the stock markets witnessed a significant rout, Humana shares have gained over 9%.

-- Edwards Lifesciences Corp EW: Cramer believes the company’s underlying stock has been strong. Edwards Lifesciences shares have lost over 42% since the beginning of the year.

Read Next: Cathie Wood Adds Another $1M In Tesla After Elon Musk's Stock Sale

Photo: Courtesy of Scott Beale on Flickr